Siemens Healthineers’ operating income slipped 11per cent in the first quarter of its fiscal year, despite higher revenues, as it sold less profitable imaging machines and incurred ramp-up costs for its new Atellica blood-testing machines.
The companies are working to establish standards to ensure merchants, consumers and autonomous AI agents are operating with sufficient risk controls and...